HEMOGLOBIN-BASED OXYGEN CARRIERS (HBOCS) - STRUCTURAL ALTERATIONS THAT AFFECT FREE-RADICAL GENERATION

被引:4
|
作者
ALAYASH, AI [1 ]
RYAN, BAB [1 ]
FRATANTONI, JC [1 ]
BONAVENTURA, J [1 ]
BONAVENTURA, C [1 ]
机构
[1] DUKE UNIV,CTR MARINE BIOMED,BEAUFORT,NC 28516
关键词
D O I
10.3109/10731199209119643
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We examined how changes in oxygen affinity brought about by different chemical modifications of hemoglobins affect their oxidation-reduction reactions. The three modified hemoglobins studied were HbA-FMDA, HbBv-FMDA, produced by the reaction of human or bovine oxyHb with fumaryl mono-dibromoaspirin; and HbA-DBBF, produced by the reaction of human deoxyHb with bis(3,5-dibromosalicyl) fumarate. Exposure of oxyHb to H2O2 causes generation of free radicals capable of cleaving dimethylsulfoxide (Me2SO) to produce formaldehyde (HCHO). Relative to the reaction rate for HbA. (630 +/- 130 M/min) the rates of HCHO formation were roughly 70 % for HbA-DBBF, 50 % for HbA-FMDA and 16 % for HbBv-FMDA. Exposure to H2O2 also caused spectral changes at varied rates for the HBOCs analyzed. Although these rates were not directly correlated with the rates of free radical formation, addition of mannitol or thiourea slowed both the rate of spectral changes and HCHO formation. The relative ability of the ferric derivatives of the HBOCs to participate in free radical reactions was monitored by assays of non-enzymatic NADPH oxidation and aniline hydroxylation. HbBv-FMDA showed significantly slower rates than the other HBOCs in both assays. The observed differences between HBOCs in these assays indicate differences in their ability to generate or interact with free radicals.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 50 条
  • [31] Hemoglobin-Based Oxygen Carriers: Availability and Case Study
    VanSandt, A.
    Friedman, K. D.
    Vanderlinden, S. E.
    Ness, P. M.
    Gottschall, J.
    TRANSFUSION, 2015, 55 : 179A - 179A
  • [32] Hemoglobin-based oxygen carriers as blood substitutes Preface
    Mozzarelli, Andrea
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (10): : 1363 - 1364
  • [33] Silk Fibroin Particles as Carriers in the Development of Hemoglobin-Based Oxygen Carriers
    Pacheco, Marisa O. O.
    Lutz, Henry M. M.
    Armada, Jostin
    Davies, Nickolas
    Gerzenshtein, Isabelle K. K.
    Cakley, Alaura S. S.
    Spiess, Bruce D. D.
    Stoppel, Whitney L. L.
    ADVANCED NANOBIOMED RESEARCH, 2023, 3 (09):
  • [34] Are newer generation hemoglobin-based oxygen carriers safe: Do they offer an answer? Introduction
    Jahr, Jonathan S.
    VASCULAR PHARMACOLOGY, 2010, 52 (5-6) : 214 - 214
  • [35] Insensitivity of cerebral oxygen transport to oxygen affinity of hemoglobin-based oxygen carriers
    Koehler, Raymond C.
    Fronticelli, Clara
    Bucci, Enrico
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (10): : 1387 - 1394
  • [36] Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally
    Meng, Fantao
    Kassa, Tigist
    Jana, Sirsendu
    Wood, Francine
    Zhang, Xiaoyuan
    Jia, Yiping
    D'Agnillo, Felice
    Alayash, Abdu I.
    BIOCONJUGATE CHEMISTRY, 2018, 29 (05) : 1560 - 1575
  • [37] Hemoglobin-based oxygen carriers: current status and future directions
    Silverman, Toby A.
    Weiskopf, Richard B.
    TRANSFUSION, 2009, 49 (11) : 2495 - 2515
  • [38] Balancing potential risks and benefits of hemoglobin-based oxygen carriers
    Weiskopf, Richard B.
    Silverman, Toby A.
    TRANSFUSION, 2013, 53 (10) : 2327 - 2333
  • [39] Hemoglobin-Based Oxygen Carriers: Where Are We Now in 2023?
    Chen, Lin
    Yang, Zeyong
    Liu, Henry
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [40] INCREASED VASCULAR-RESISTANCE WITH HEMOGLOBIN-BASED OXYGEN CARRIERS
    HESS, JR
    MACDONALD, VW
    GOMEZ, CS
    COPPES, V
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (03): : 361 - 372